129 related articles for article (PubMed ID: 9325069)
1. Extracellular matrix remodeling in coxsackievirus B3 myocarditis.
Kishimoto C; Kitazawa M; Hiraoka Y; Takada H
Clin Immunol Immunopathol; 1997 Oct; 85(1):47-55. PubMed ID: 9325069
[TBL] [Abstract][Full Text] [Related]
2. Interstitial fibrin-fibronectin deposition with T cell infiltrates precedes fibrosis in murine viral myocarditis.
Kishimoto C; Kitazawa M; Takada H
Int J Exp Pathol; 1998 Dec; 79(6):417-23. PubMed ID: 10319022
[TBL] [Abstract][Full Text] [Related]
3. T cell-mediated immune response enhances the severity of myocarditis in secondary cardiotropic virus infection in mice.
Kishimoto C; Hiraoka Y; Takada H
Basic Res Cardiol; 2001 Sep; 96(5):439-45. PubMed ID: 11605990
[TBL] [Abstract][Full Text] [Related]
4. In vivo significance of T cells in the development of Coxsackievirus B3 myocarditis in mice. Immature but antigen-specific T cells aggravate cardiac injury.
Kishimoto C; Abelmann WH
Circ Res; 1990 Sep; 67(3):589-98. PubMed ID: 1697791
[TBL] [Abstract][Full Text] [Related]
5. Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage.
Kishimoto C; Kuroki Y; Hiraoka Y; Ochiai H; Kurokawa M; Sasayama S
Circulation; 1994 Jun; 89(6):2836-42. PubMed ID: 8205699
[TBL] [Abstract][Full Text] [Related]
6. The role of T lymphocytes in the pathogenesis of Coxsackie virus B3 heart disease.
Hashimoto I; Tatsumi M; Nakagawa M
Br J Exp Pathol; 1983 Oct; 64(5):497-504. PubMed ID: 6315043
[TBL] [Abstract][Full Text] [Related]
7. Coxsackievirus B3 persistence and myocarditis in N:NIH(S) II nu/nu and +/nu mice.
Schnurr DP; Cao Y; Schmidt NJ
J Gen Virol; 1984 Jul; 65 ( Pt 7)():1197-201. PubMed ID: 6747601
[TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix remodelling after coxsackievirus B3-induced murine myocarditis.
Gómez RM; Castagnino CG; Berría MI
Int J Exp Pathol; 1992 Oct; 73(5):643-53. PubMed ID: 1329915
[TBL] [Abstract][Full Text] [Related]
9. Immunological mechanisms in experimental coxsackievirus B3 myocarditis in mice.
Kishimoto C; Ochiai H; Sasayama S
Jpn Circ J; 1991 Nov; 55(11):1144-8. PubMed ID: 1721094
[TBL] [Abstract][Full Text] [Related]
10. Coxsackievirus B3 persistence and myocarditis in NFR nu/nu and +/nu mice.
Schnurr DP; Schmidt NJ
Med Microbiol Immunol; 1984; 173(1):1-7. PubMed ID: 6088960
[TBL] [Abstract][Full Text] [Related]
11. IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis.
Guo Y; Wu W; Cen Z; Li X; Kong Q; Zhou Q
Virol J; 2014 Dec; 11():230. PubMed ID: 25547181
[TBL] [Abstract][Full Text] [Related]
12. Modulation of cytokine expression by CD4+ T cells during coxsackievirus B3 infections of BALB/c mice initiated by cells expressing the gamma delta + T-cell receptor.
Huber SA; Mortensen A; Moulton G
J Virol; 1996 May; 70(5):3039-44. PubMed ID: 8627781
[TBL] [Abstract][Full Text] [Related]
13. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice.
Huber SA
Lab Invest; 1997 May; 76(5):691-701. PubMed ID: 9166288
[TBL] [Abstract][Full Text] [Related]
14. Coxsackie B3 myocarditis in athymic mice.
Robinson JA; O'Connell JB; Roeges LM; Major EO; Gunnar RM
Proc Soc Exp Biol Med; 1981 Jan; 166(1):80-91. PubMed ID: 6258175
[No Abstract] [Full Text] [Related]
15. Depressed unloaded sarcomere shortening velocity in acute murine coxsackievirus myocarditis: myocardial remodelling in the absence of necrosis or hypertrophy.
Hamrell BB; Huber SA; Leslie KO
Eur Heart J; 1995 Dec; 16 Suppl O():31-5. PubMed ID: 8682097
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis in coxsackievirus B3-induced myocarditis and dilated cardiomyopathy.
Huber SA; Budd RC; Rossner K; Newell MK
Ann N Y Acad Sci; 1999; 887():181-90. PubMed ID: 10668474
[TBL] [Abstract][Full Text] [Related]
18. Myocardial fibrin deposition in experimental viral myocarditis that progresses to dilated cardiomyopathy.
Schnitt SJ; Stillman IE; Owings DV; Kishimoto C; Dvorak HF; Abelmann WH
Circ Res; 1993 Apr; 72(4):914-20. PubMed ID: 7680288
[TBL] [Abstract][Full Text] [Related]
19. Coxsackievirus B3-induced chronic myocarditis in mouse: use of whole blood culture to study the activation of TNF alpha-producing cells.
Hober D; Andreoletti L; Shen L; Copin MC; Desmidt A; Wattré P
Microbiol Immunol; 1996; 40(11):837-45. PubMed ID: 8985939
[TBL] [Abstract][Full Text] [Related]
20. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions.
Sato S; Tsutsumi R; Burke A; Carlson G; Porro V; Seko Y; Okumura K; Kawana R; Virmani R
J Gen Virol; 1994 Nov; 75 ( Pt 11)():2911-24. PubMed ID: 7964602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
